Salute e Benessere

Akari Therapeutics Secures $7.6 Million in Upsized Financing Round

BOSTON and LONDON, June04, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory diseases, today announced the successful initial closing of a private placement financing round. This transaction is expected to raise an aggregate of approximately $7.6 million in gross proceeds from both new and existing investors. "We are pleased to announce this financing for Akari Therapeutics," said Samir…
Nasdaq GlobeNewswire
04/06/2024

Evolution Optiks Receives U.S. FDA 510(k) Clearance for Breakthrough Eye…

The LFR-260 is a compact, portable, fully digital device that can be operated remotely from anywhere in the world via tablet which makes it ideal for telemedicine. Its integrated micro lens arrays and ultra-high pixel density displays enable it to generate ray-traced, multi-focal optotypes, in real-time, making dedicated refraction rooms, wall charts, and back-and-forth changing of physical lenses a thing of the past. The proprietary QuadView™ technology can show multiple slightly different…
PR Newswire
04/06/2024

Businesses Have One Year to Prepare and Comply with the European Accessibility…

The EAA was enacted April 2019 and requires product manufacturers and service providers active in EU member states to meet the requirements of the legislation by June 28, 2025. The EAA applies to most companies providing certain goods and services in the EU, with a primary focus on the accessibility of digital assets such as websites and mobile applications and excluding microenterprises that provide services only. The EAA was enactedApril 2019and requires product manufacturers and service...
PR Newswire
04/06/2024

Masdar City to Showcase Its Life Sciences Hub at BIO24 in San Diego

Masdar City's involvement at BIO24 aligns with the Government of Abu Dhabi's strategic ambition - 'Abu Dhabi Vision 2030' - which prioritizes the development of the life sciences industry as a key driver of economic diversification. Supported by the UAE government's strategic initiatives, Masdar City is fostering a vibrant ecosystem that promotes scientific research, innovation, and commercialization. Masdar City's involvement at BIO24 aligns with the Government ofAbu Dhabi'sstrategic...
PR Newswire
04/06/2024

Counsellingo.com: A new professional directory of over a thousand self-employed…

Witney was the co-founder of the world's first internet recruitment service, JobServe, back in 1994. In 2000 JobServe was top of the Sunday Times Profit Track 100 league table, and in 2001 JobServe was the first 'dot com' business to receive a Queen's Award for Enterprise. Witney was the co-founder of the world's first internet recruitment service,JobServe, back in 1994. In 2000 JobServe was top of theSunday Times Profit Track 100league table, and in 2001 JobServe was the first 'dot com'...
PR Newswire
04/06/2024

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses…

Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare and industrial growth companies. Endpoint and FPA provide best-in-class...
Nasdaq GlobeNewswire
04/06/2024

RNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6%…

RNA interference (RNAi) is an advanced biological process intrinsic to cells, complexly organizing gene expression through precise sequence-directed silencing. Leveraging this mechanism, RNAi therapeutics have emerged as a pioneering drug class, harnessing genes inherent in RNAi properties to regulate cellular expression systems naturally. Their potential to treat a diverse range of conditions, from metabolic and chronic diseases to cancer, has propelled RNAi therapeutics into the spotlight of…
PR Newswire
04/06/2024

Bioimplants Market to Reach $364.8 Billion, Globally, by 2035 at 8.8% CAGR…

Prime determinants of growth Prime determinants of growth The bioimplants market is expected to grow significantly owing to rise in prevalence of cardiovascular diseases, surge in geriatric population, and high adoption of the orthopedic implants for the treatment of joints and other complications. The exponential rise in the prevalence of cardiovascular diseases (CVDs) has emerged as a significant driver propelling the growth of the bioimplants market. Report coverage & details:...
PR Newswire
04/06/2024

Pioneering Innovation from MolecuLight Earns Best Abstract at SAWC Spring 2024

Dr. Charles Andersen, lead author of the study, expressed his enthusiasm about the recognition received at the Symposium for Advanced Wound Care. He stated, "This award is a testament to the potential impact of our research in advancing wound care practices. By integrating multi-modal fluorescence and thermal imaging technologies, we aim to revolutionize the way healthcare professionals assess and manage wounds." Dr.Charles Andersen, lead author of the study, expressed his enthusiasm…
PR Newswire
04/06/2024

Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 |…

Key Takeaways from the Thrombectomy Devices Market Report Key Takeaways from the Thrombectomy Devices Market Report To read more about the latest highlights related to the thrombectomy devices market, get a snapshot of the key highlights entailed in theGlobal Thrombectomy Devices Market Report Thrombectomy Devices Overview Thrombectomy devices represent a groundbreaking advancement in the field of interventional medicine, offering a minimally invasive solution for treating...
PR Newswire
04/06/2024

Department of Health - Abu Dhabi Partners with Pfizer to Advance Research in…

Dr Asma Ibrahim Al Mannaei, said: "The collaboration between the DoH and Pfizer represents a significant step towards harnessing real-world data in the region and better understanding patient populations from the vast available data in Abu Dhabi. By partnering with Pfizer on real-world data, we aim to drive advancements in healthcare prediction, prevention, personalised treatment and access, not only benefiting healthcare professionals and patients in Abu Dhabi, but also contributing to the…
PR Newswire
04/06/2024

The COSMETIC 360 international trade show will celebrate 10 years of cosmetics…

Organised by COSMETIC VALLEY, the world's leading fragrance and cosmetics network and coordinator of the French industry for 30 years, this 10 thedition will bring together 250 exhibitors and over 5,000 international decision-makers from 70 countries to discuss the latest innovations in the industry. The theme of longevity and sustainability will be the focus of this anniversary event. And to mark its 10 thedition in this Olympic year, COSMETIC 360 will be organising the...
PR Newswire
04/06/2024

PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer

Regarding this disease, the results presented by the company at ASCO show that the combination of its drug for this pathology, Zepzelca® (lurbinectedin), in combination with irinotecan produces a synergy that enhances the activity of lurbinectedin, resulting in high and durable response rates in populations that are sensitive, with a chemotherapy-free interval greater than 90 days (CTFI> 90 days), and platinum-resistant with a chemotherapy-free interval of less than 90 days (CTF< 90 days)…
PR Newswire
04/06/2024

ATTEND FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT SHOWCASING SUSTAINABLE…

"We are delighted to bring back the Sustainability in Dentistry Summit this year, reaffirming our dedication to shaping a more sustainable future. Environmental responsibility is critical in dentistry, a commitment we owe to our planet and future generations. We invite all stakeholders to engage in this enlightening three-day event and join us in fostering a healthier, eco-conscious approach to oral healthcare." – Dr Greg Chadwick, FDI President "We are delighted to bring back…
PR Newswire
04/06/2024

Sectra adds IT solution for genomics in cancer diagnostics--first deployment at…

Analysis of genetic information, genomics, is increasingly used in healthcare today to better diagnose and treat patients. Individualized care based on, among other data, genetic information is often referred to as precision medicine and is a rapidly growing field. Analysis of genetic information, genomics, is increasingly used in healthcare today to better diagnose and treat patients. Individualized care based on, among other data, genetic information is often referred to as precision...
PR Newswire
04/06/2024

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in…

ForTec has initiated procedures in select territories with the 6 Saphira towers that it currently has in the field, and an expanded rollout of the program throughout the U.S. is anticipated to commence in the third quarter of 2024 with 12 additional Saphira towers that ForTec is preparing for deployment. ForTec has initiated procedures in select territories with the 6 Saphira towers that it currently has in the field, and an expanded rollout of the program throughout the U.S. is anticipated…
PR Newswire
04/06/2024

UNION therapeutics announces successful completion of the ADESOS Phase 2b study…

Presentation details Presentation details Presentation: Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a Phase2brandomized, double-blind, placebo-controlled clinical trial (ADESOS) Presenter: Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at TheGeorge Washington University School of Medicineand Health Sciences and Signatory Investigator for ADESOS Date and time: Monday June 10, 2024, at...
PR Newswire
04/06/2024

Global Heart Hub urges people to "Think Cardiomyopathy" with new Global Campaign

Think Cardiomyopathy Think Cardiomyopathy Led by GHH's Cardiomyopathy Patient Council which has 24 patient organisation affiliates across 15 countries, this year's campaign focuses on patient and advocate stories on the impact of cardiomyopathy and the importance of recognising symptoms and knowing your family history. "Cardiomyopathy is too often underdiagnosed, misdiagnosed or diagnosed too late. It is the predominant cause of sudden cardiac death in people under 35. We want to raise...
PR Newswire
04/06/2024

Nyxoah to Participate in the Jefferies Global Healthcare Conference

Nyxoah to Participate in the Jefferies Global Healthcare ConferenceMont-Saint-Guibert, Belgium – June 3, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies Global Healthcare Conference, which takes place June 5 – 6, 2024 in New York...
Nasdaq GlobeNewswire
03/06/2024

Information on the total number of voting rights and shares

REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert (Belgium), June 3, 2024, 10:15 pm CET / 4:15 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,902,793.43 Total number of securities carrying voting rights: 34,360,390 (all ordinary...
Nasdaq GlobeNewswire
03/06/2024

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve…

ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3Sarclisa, in combination with standard-of-care bortezomib, lenalidomide and dexamethasone (VRd) followed by Sarclisa-Rd reduced the risk of recurrence or death by 40% versus VRd followed by Rd in the investigational use for transplant-ineligible newly diagnosed multiple myeloma patientsKey primary endpoint of...
Nasdaq GlobeNewswire
03/06/2024

Publication relating to transparency notifications

REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert (Belgium), June 3, 2024, 10.05pm CET / 4.05pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received four transparency notifications as detailed below.FMR LLCOn May 30, 2024, Nyxoah received a transparency notification from FMR LLC following the crossing above the 3%...
Nasdaq GlobeNewswire
03/06/2024

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

/48th of the aggregate number of shares subject to the award on each monthly anniversary of the grant date thereafter, such that the entire award will be vested as of the fourth anniversary of the grant date, subject to continued employment with the Company. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment...
Nasdaq GlobeNewswire
03/06/2024

Biesterfeld Group acquires Aerontec and expands its presence in Africa

Dirk J. Biesterfeld, Chairman of the Supervisory Board of Biesterfeld AG, explains: "The sub-Saharan region is of high interest for Biesterfeld. With this acquisition, we are not only pursuing our global growth strategy but have also gained a great team, which shares the same goals and values that we hold at Biesterfeld. I welcome Graham Blyth and all new colleagues as part of our Biesterfeld family. We are looking forward to a successful future together." Dirk J. Biesterfeld, Chairman…
PR Newswire
03/06/2024
Altri  Comunicati